fpl 55712 has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denzlinger, C; Hagmann, W; Keppler, D | 1 |
| Falk, A; Haglund, U; Schützer, KM | 1 |
2 other study(ies) available for fpl 55712 and Shock, Septic
| Article | Year |
|---|---|
Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Bile; Chromones; Dexamethasone; Diethylcarbamazine; Endotoxins; Female; Ibuprofen; Indomethacin; Leukotriene B4; Liver; Metabolic Clearance Rate; Mice; Pyrazoles; Rats; Rats, Inbred Strains; Shock, Septic; SRS-A | 1984 |
Cardiopulmonary dysfunction in a feline septic shock model: possible role of leukotrienes.
Topics: Airway Resistance; Animals; Blood Pressure; Cats; Chromones; Diethylcarbamazine; Escherichia coli Infections; Heart; Hemodynamics; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Compliance; Platelet Count; Shock, Septic; SRS-A; Vascular Resistance | 1989 |